You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 19, 23 OCTOBER 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Beneficial Effect of Digoxin-Specific Fab Antibody Fragments in Oleander Intoxication

Rifaat Safadi, MD; Izhar Levy, MD; Yona Amitai, MD; Yoseph Caraco, MD

Arch Intern Med. 1995;155(19):2121-2125.


Abstract

A 24-year-old man presented to the emergency department with nausea, vomiting, abdominal pain, and an acute confusional state of 6 hours' duration. Ten hours before admission, he had ingested a mixture of orange juice and six ground leaves, later identified as Nerium oleander (common pink oleander) leaves. His blood pressure was 100/80 mm Hg, and his pulse rate was irregular at 40/min. He was disoriented and his speech was dysarthric. Twelve-lead electrocardiography revealed a complete atrioventricular block, with a nodal escape rhythm of 40/min and diffuse ST depression. The presumptive diagnosis of acute oleander intoxication was confirmed by the detection of digoxin (1.0 nmol/L [0.8 ng/mL]) on radioimmunoassay. Despite intensive therapy, the patient's hemodynamic condition deteriorated. His blood pressure decreased to 70/40 mm Hg; he became oliguric and nonresponsive to external stimuli; and his potassium concentration rose to 6.8 mmol/L. Eighteen hours after admission, an empiric 480-mg dose of digoxin-specific Fab antibody fragments was administered intravenously over 30 minutes. Within minutes of the initiation of immunotherapy, the patient woke up; his blood pressure rose to 90/50 mm Hg; and he regained a sinus rhythm of 68/min with a prolonged PR interval. His potassium concentration decreased to 5.1 mmol/L within 15 minutes and normalized within 1 hour of therapy initiation. One day later, the 1° atrioventricular block disappeared, but the ST depression persisted for an additional 6 days. The value of digoxin-specific Fab antibody fragments in the treatment of plant glycoside and, in particular, oleander intoxication is discussed.

(Arch Intern Med. 1995;155:2121-2125)



Author Affiliations

From the Division of Medicine (Drs Safadi, Levy, and Caraco), the Department of Pediatrics (Dr Amitai), and the Clinical Pharmacology Unit (Dr Caraco), Hadassah University Hospital, Jerusalem, Israel.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Benefits, adverse effects and drug interactionsof herbal therapies with cardiovascular effects
Valli and Giardina
J Am Coll Cardiol 2002;39:1083-1095.
ABSTRACT | FULL TEXT  

Management of acute yellow oleander poisoning
Eddleston and Warrell
QJM 1999;92:483-485.
FULL TEXT  

Herbal Medicine for the Treatment of Cardiovascular Disease: Clinical Considerations
Mashour et al.
Arch Intern Med 1998;158:2225-2234.
ABSTRACT | FULL TEXT  

Contamination of Botanical Dietary Supplements by Digitalis lanata
Slifman et al.
NEJM 1998;339:806-811.
FULL TEXT  

Monitoring of Unbound Digoxin in Patients Treated with Anti-Digoxin Antigen-binding Fragments: A Model for the Future?
Valdes and Jortani
Clin. Chem. 1998;44:1883-1885.
FULL TEXT  

Standards of laboratory practice: cardiac drug monitoring
Valdes et al.
Clin. Chem. 1998;44:1096-1109.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.